Magnetic resonance imaging of the liver and spleen in the diagnosis of storage diseases

Storage diseases (thesaurismoses, storage reticuloses) are the common name of a large group of hyperplastic non-leukemic diseases characterized by congenital or acquired metabolic disturbances and abnormal accumulation of metabolic products in blood and/or cells of different organs and by hyperplasia of mononuclear phagocyte elements in the liver, spleen, bone marrow, lymph nodes, and other organs, which makes the diseases systemic. Among the imaging techniques for diffuse liver diseases, ultrasonography and X-ray computed tomography are most commonly used for their diagnosis and follow-up. Magnetic resonance imaging (MRI) has the highest sensitivity and specificity in diagnosing liver diseases. The paper considers the current MRI procedures that are used to diagnose storage diseases and to quantify found changes. For Gaucher’s disease, the potentials of novel techniques, such as MR spectroscopy, diffusion-weighted imaging (DWI), and chemical shift imaging (Dickson’s method) for the estimation of revealed changes, are described. For hemochromatosis, the contribution of T2 WI to the quantification of iron overload in the liver parenchyma is depicted, which is an alternative invasive procedure in its determination.
Incorporation of MRI into the examination algorithm for patients with storage
diseases will be able to improve the detection of these rare diseases and to monitor
the efficiency of performed therapy.

Gaucher’s disease, hemochromatosis, magnetic resonance imaging, T2-weighted imaging, diffusion-weighted imaging

1. Smirnov V.P., Fadeev M.Yu. Storage disease (thesaurismosis). N. Novgorod; 2007 (in Russian).

2. Pal’tsev M.A., Paukov V.S., Ulumbekov E.G. (eds). Pathology. Guidance. Moscow: GEOTAR-MED; 2002 (in Russian).

3. Pal’tsev M.A., Anichkov N.M. Pathological anatomy. Textbook. Moscow: Meditsina; 2001 (in Russian).

4. Saltykov B.B. Cell dystrophy. In: Pal’tsev M.A., Paukov V.S., Ulumbekov E.G. (eds). Pathology. Guidance. Moscow: GEOTAR-MED; 2002: 20–31 (in Russian).

5. Arablinskiy A.V., Chechenov M.Kh. To the question about non-invasive diagnostics of steatosis in non-alcoholic steatohepatitis. Radiologiya–praktika. 2007; 4: 16–28 (in Russian).

6. Banerjee R., Pavlides M., Tunnicliffe E.M., Piechnik S.K. et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J. Hepatol. 2014; 60 (1): 69–77.

7. Merra G., Lago A., Ricci R., Antuzzi D. et al. Splenomegaly as a primary manifestation of Gaucher’s disease in a young adult woman. Case Rep. Gastroenterol. 2008; 2 (3): 474–8.

8. Лукина Е.А. Болезнь Гоше: Практическое руководство. М.: Литтерра; 2012.

9. Kalayci T.O., Erdem G., Kutlu R. et al. Diffusion-weighted magnetic resonance imaging and magnetic resonance spectroscopy features of abdominal viscera in a patient with Gaucher’s disease. Malays J. Med. Sci. 2014; 21 (3): 89–93.

10. Rosenthal D.I., Scott J.A., Barranger J., Mankin H.J. et al. Evaluationof Gaucher disease using magnetic resonance imaging. J. Bone Joint. Surg. Am. 1986; 68 (6): 802–8.

11. Strukov A.I., Serov V.V. Pathological anatomy. 5th ed. Moscow: Litterra; 2010: 90–3 (in Russian).

12. Shimanovskiy N.L., Kotlyarov P.M., Solodkiy V.A., Sergeev N.I. Magnetic resinance imaging of the liver with hepatotropic paramagnetic contrast media in diagnosis of focal liver pathology. Meditsinskaya vizualizatsiya. 2011; 2: 26–32 (in Russian).

13. Vlasov P.V., Kotlyarov P.M. Radiology of spleen diseases. Vestnik rentgenologii i radiologii. 1997; 3: 23–30 (in Russian).

14. Bacon B.R., Adams P.C., Kowdley K.V., Powell L.W., Tavill A.S. Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011; 54 (1): 328–43.

15. Tziomalos K., Perifanis V. Liver iron content determination by magnetic resonance imaging. World J. Gastroenterol. 2010; 16 (13): 1587–97. 16. Hoffbrand A.V., Taher A., Cappellini M.D. How I treat transfusional iron overload. Blood. 2012; 120: 3657–69.

16. Zamani F., Razmjou S., Akhlaghpoor S., Eslami S.-M. et al. T2* magnetic resonance imaging of the liver in thalassemic patients in Iran. World J. Gastroenterol. 2011; 17 (4): 522–5.

17. Wood J.C. Magnetic resonance imaging measurement of iron overload. Curr. Opin. Hematol. 2007; 14 (3): 183–90.

18. Wood J.C., Fassler J.D., Meade T. Mimicking liver iron overload using liposomal ferritin preparations. Magn. Reson. Med. 2004; 51 (3): 607–11.

19. Dvoryakovskaya Yu.O., Gundobina S., Dvoryakovskiy I.V., Egorova M.V., Basistova A.A. Estimation of Gaucher’s disease treatment effectiveness in children by ultrasound data. Ul’trazvukovaya i funktsional’naya diagnostika. 2006; 3: 33–40 (in Russian).

20. Simpson W.L., Hermann G., Balwani M. Imaging of Gaucher’s disease. World J. Radiol. 2014; 6 (9): 657–68.

21. Zedgenidze G.A. (ed.) Clinical radiology. Moscow: Meditsina; 1984; 3: 384–5 (in Russian).

22. Katz D.S., Gold B.M., Groskin S.A. et al. Секреты рентгенологии. M.: Бином-пресс; 2003.

23. Ooi G.C., Chen F.E., Chan K.N., Tsang K.W. et al. Qualitative and quantitative magnetic resonance imaging in haemoglobin H disease: screening for iron overload. Clin. Radiol. 1999; 54 (2): 98–102.

24. Smetanina N.S. Treatment of posttransfusal iron overload. Detskaya bol’nitsa. 2009; 1: 43–6 (in Russian).

25. Terk M.R., Dardashti S., Liebman H.A. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal. Radiol. 2000; 29 (10): 563–71.

26. Dixon W.T. Simple proton spectroscopic imaging. Radiology. 1984; 153 (1): 189–94.

27. Maas M., Hollak C.E., Akkerman E.M., Aerts J.M. et al. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR. 2002; 179: 961.

28. Poll L.W., Koch J.A., vom Dahl S., Willers R.et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol. 2001; 30 (9): 496–503.

29. Terk M.R., Dardashti S., Liebman H.A. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol. 2000; 29 (10): 563–71.

30. Maas M., van Kuijk C., Stoker J., Hollak C.E. et al. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging-initial experience. Radiology. 2003; 229 (2): 554–61.

31. DeMayo R.F., Haims A.H., McRae M.C., Yang R., Mistry P.K. Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease. AJR. 2008; 191 (1): 115–23.